Acute myocardial infarction in sickle cell disease: a systematic review

Rajmony Pannu1, Jun Zhang, Richard Andraws

  • 1Department of Internal Medicine, New Hanover Regional Medical Center, Wilmington, North Carolina 28401, USA. pannu.rajmony@gmail.com

Insights

Myocardial infarction is frequently missed in young sickle cell disease patients due to atypical symptoms and low-risk scores. Early diagnosis and tailored management are crucial for this vulnerable population.

Area of Science:

  • Cardiology
  • Hematology
  • Internal Medicine

Background:

  • Myocardial infarction (MI) in young adults is often a diagnosis of exclusion.
  • Sickle cell disease (SCD) patients are disproportionately young and prone to crises, leading to overlooked MI.
  • Traditional coronary artery disease risk factors and stratification tools (TIMI, GRACE) underestimate MI risk in SCD.

Purpose of the Study:

  • To highlight the challenges in diagnosing MI in young adults with SCD.
  • To discuss the diagnostic criteria, potential mechanisms, and management strategies for MI in SCD patients.
  • To emphasize the need for increased awareness and revised diagnostic approaches for MI in this population.

Main Methods:

  • Review of existing literature on MI in young adults and SCD.
  • Analysis of diagnostic challenges, including atypical presentations and limitations of risk scores.
  • Discussion of pathophysiological mechanisms linking SCD to cardiac events.
  • Outline of current and potential management strategies.

Main Results:

  • MI is often a missed diagnosis in SCD patients.
  • Nonspecific electrocardiogram changes offer limited diagnostic value.
  • SCD patients frequently lack traditional cardiovascular risk factors, complicating risk assessment.
  • Existing risk stratification models are inadequate for identifying MI risk in SCD.

Conclusions:

  • MI in young adults with SCD requires heightened clinical suspicion.
  • Diagnostic criteria and risk assessment tools need adaptation for SCD patients.
  • Understanding SCD-specific mechanisms is key to improving MI diagnosis and management.
  • Prompt and appropriate management can improve outcomes for SCD patients experiencing MI.

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...